Overall Technical outlook

Price Summary

Eris Lifesciences Limited's stock started trading at 1774.8 on 2025-09-03, climbed to 1799.0, fell to 1751.0, and closed 0.29% higher at 1779.9, with 49511 shares traded.
The stock's highest price in the past 52 weeks is 1847.7, while its lowest price during the same period is 1153.1.
The future price of ERIS is projected to range from 1680.0 to 2000.0, with an average expected price of 1860.1, according to 10 analysts.

Technicals

Support and Resistance: The price currently sits at 1779.9, finding support at 1683.8 and resistance at 1792.1. These levels define a range for Eris Lifesciences Limited where the price may move, with 1683.8 offering a base and 1792.1 limiting upward momentum.
ERIS supportResistance 54e8da
Support/Resistance for ERIS


Aroon: The AROON is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
ERIS aroon 54e8da
Aroon chart for Eris Lifesciences Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for ERIS, with no strong trend emerging.
ERIS bbands 54e8da
Bolinger Bands chart for Eris Lifesciences Limited


Parabolic SAR: The PSAR continues to indicate a bullish outlook, establishing a key support level that could sustain the market's upward trend. This support suggests that the bullish momentum is likely to persist, offering a foundation for further growth.
ERIS psar 54e8da
Parabolic Stop and Reverse chart for Eris Lifesciences Limited


Stochastic: The STOCHASTIC is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
ERIS stoch 54e8da
Stochastic chart for Eris Lifesciences Limited


Tripple Moving Agerage: The Tripple MOVING AVG is in a neutral stance for ERIS, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
ERIS trippleSMA 54e8da
Tripple SMA chart for Eris Lifesciences Limited


When evaluating a company's technical data, such as stock price charts or volume, it is essential to first consider its fundamentals. These fundamentals include financial stability, growth potential, and competitive advantages. Additionally, understanding the broader industry in which the company operates offers context that helps to make sense of technical patterns. By examining both the company's internal strengths and external environment, one can make more accurate and meaningful conclusions about its stock performance.